Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (391-400 of 688) with videos related to

Pageof 69
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|October 9, 2024
Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysisBertram Pitt, Rajiv Agarwal, Stefan D Anker, et al.
Kidney International|April 23, 2025
Analysis of the prespecified FIDELITY pooled patient dataset examined the efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rateSankar D Navaneethan, Stefan D Anker, Gerasimos Filippatos, et al.
European Journal of Heart Failure|May 22, 2012
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)David Preiss, Dirk J van Veldhuisen, Naveed Sattar, et al.
European Journal of Heart Failure|September 3, 2019
Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failureStefano Coiro, Nicolas Girerd, Abhinav Sharma, et al.
European Journal of Heart Failure|September 18, 2021
Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALESSu E Yeoh, Pooja Dewan, Matteo Serenelli, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure controlKenneth A Jamerson, Richard Devereux, George L Bakris, et al.
International Journal of Cardiology|October 16, 2010
Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched studyMustafa I Ahmed, Marjan Mujib, Ravi V Desai, et al.
Journal of the American College of Cardiology|April 25, 2015
Patient selection in heart failure with preserved ejection fraction clinical trialsJacob P Kelly, Robert J Mentz, Alexandre Mebazaa, et al.
European Heart Journal|May 9, 2026
Guideline-recommended medical therapy efficacy according to use of digoxin: RALES, EMPHASIS-HF, PARADIGM-HF, and DAPA-HF trialsRagnhild Helseth, Ryohei Ono, Brian Claggett, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 29, 2016
Effect of Patiromer on Urinary Ion Excretion in Healthy AdultsDavid A Bushinsky, David M Spiegel, Coleman Gross, et al.
Pageof 69

Showing results (391-400 of 688) with videos related to

Sort By:
Pageof 69
European Heart Journal. Cardiovascular Pharmacotherapy|October 9, 2024
Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysisBertram Pitt, Rajiv Agarwal, Stefan D Anker, et al.
Kidney International|April 23, 2025
Analysis of the prespecified FIDELITY pooled patient dataset examined the efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rateSankar D Navaneethan, Stefan D Anker, Gerasimos Filippatos, et al.
European Journal of Heart Failure|May 22, 2012
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)David Preiss, Dirk J van Veldhuisen, Naveed Sattar, et al.
European Journal of Heart Failure|September 3, 2019
Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failureStefano Coiro, Nicolas Girerd, Abhinav Sharma, et al.
European Journal of Heart Failure|September 18, 2021
Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALESSu E Yeoh, Pooja Dewan, Matteo Serenelli, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure controlKenneth A Jamerson, Richard Devereux, George L Bakris, et al.
International Journal of Cardiology|October 16, 2010
Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched studyMustafa I Ahmed, Marjan Mujib, Ravi V Desai, et al.
Journal of the American College of Cardiology|April 25, 2015
Patient selection in heart failure with preserved ejection fraction clinical trialsJacob P Kelly, Robert J Mentz, Alexandre Mebazaa, et al.
European Heart Journal|May 9, 2026
Guideline-recommended medical therapy efficacy according to use of digoxin: RALES, EMPHASIS-HF, PARADIGM-HF, and DAPA-HF trialsRagnhild Helseth, Ryohei Ono, Brian Claggett, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 29, 2016
Effect of Patiromer on Urinary Ion Excretion in Healthy AdultsDavid A Bushinsky, David M Spiegel, Coleman Gross, et al.
Pageof 69